ReviewCurrent oncology (Toronto, Ont.)2020

Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia.

V Banerji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.